LOGC
LogicBio Therapeutics, Inc. Common Stock
LOGC
LOGC
Delisted
LOGC was delisted on the 15th of November, 2022.
57 hedge funds and large institutions have $37M invested in LogicBio Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
84% less call options, than puts
Call options by funds: $5K | Put options by funds: $32K
Holders
57
Holding in Top 10
–
Calls
$5K
Puts
$32K
Top Buyers
| 1 | +$1.08M | |
| 2 | +$200K | |
| 3 | +$86.2K | |
| 4 |
William Blair & Company
Chicago,
Illinois
|
+$51K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$43K |
Top Sellers
| 1 | -$2.29M | |
| 2 | -$301K | |
| 3 | -$216K | |
| 4 |
HF
HRT Financial
New York
|
-$192K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$181K |